Generated by AI
111, Inc. is a healthcare technology and pharmaceutical distribution company serving consumers, pharmacies, pharmaceutical manufacturers, and healthcare professionals in China. Its integrated platform combines online retail, wholesale distribution, and technology-enabled services across business-to-consumer and business-to-business segments. Through its consumer channels, the company provides prescription and over-the-counter medicines, traditional and Western healthcare products, nutritional supplements, medical supplies, personal care items, and wellness products. Its business-to-business operations support pharmacies with pharmaceutical procurement, supply-chain integration, warehousing, logistics, inventory management, and digital purchasing tools. 111, Inc. also provides pharmaceutical manufacturers with product promotion, customer analytics, patient education, brand-support services, and channel data. Additional digital capabilities include online consultations, electronic prescriptions, pharmacy financing applications, and software tools for sales and inventory management. Headquartered in Shanghai, China, the company connects healthcare brands, pharmacies, and patients through an omnichannel infrastructure, helping digitize pharmaceutical commerce and improve access to healthcare products across China.
WebsiteNo.295 ZuChongZhi Road
Shanghai, 201203
China
The latest articles about YI.
111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising of three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, has been established by the Company's Board of Directors to consider and evaluate the previously announced preliminary, non-binding proposal letter dated September 16, 2026 (the "Pr
Detailed price information for 111 Inc ADR (YI-Q) from The Globe and Mail including charting and trades.
Summary of Mar 5's posts. Generated by AI.
Summary of Jan 30's posts. Generated by AI.
Detailed price information for 111 Inc ADR (YI-Q) from The Globe and Mail including charting and trades.
Summary of Jan 14's posts. Generated by AI.
Investors talking about YI also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.